Results for “stigma”
Chronic Fatigue Syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, chronic illness characterized by profound fatigue, sleep disturbances, and cognitive impairments, with post-exertional malaise being a hallmark symptom. ## Overview Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic and debilitating illness that affects millions of people worldwide. Despite its prevalence, ME/CFS remains poorly understood, and its diagnosis and treatment are often shrouded in controversy. People with ME/CFS experience a wide range of symptoms, including fatigue that is not relieved by rest, sleep disturbances, memory and concentration problems, and pain. The most distinctive feature of ME/CFS is post-exertional malaise (PEM), a worsening of symptoms that can occur after even minor physical or mental activity. ME/CFS is often referred to as a "hidden" illness, as its symptoms can be subtle and may not be immediately apparent. However, the impact of ME/CFS on daily life can be profound, with many people experiencing significant limitations in their ability to work, engage in social activities, and participate in daily tasks. The exact cause of ME/CFS is still unknown, and there is no cure. However, research is ongoing to better understand the underlying mechanisms of the illness and to develop effective treatments. ## History/Background The term "chronic fatigue syndrome" (CFS) was first coined in the 1980s, although the illness itself has been described in medical literature for centuries. In the 19th century, the term "neurasthenia" was used to describe a condition characterized by fatigue, anxiety, and depression. In the 1950s and 1960s, the term "post-viral fatigue syndrome" was used to describe a condition that developed after viral infections. In the 1980s, the term "chronic fatigue syndrome" was adopted, and the illness was recognized as a distinct medical condition. In the 1990s, the term "myalgic encephalomyelitis" (ME) was reintroduced, and it is now widely used to describe the more severe form of the illness. ME/CFS is recognized as a chronic and debilitating condition by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). Despite its recognition as a legitimate medical condition, ME/CFS remains poorly understood, and its diagnosis and treatment are often shrouded in controversy. ## Key Information * **Prevalence:** ME/CFS affects an estimated 836,000 to 2.5 million people in the United States alone. * **Symptoms:** Fatigue that is not relieved by rest, sleep disturbances, memory and concentration problems, pain, and post-exertional malaise (PEM). * **Causes:** Unknown, but may be related to viral infections, immune system dysfunction, and genetic predisposition. * **Diagnosis:** Based on a combination of medical history, physical examination, and laboratory tests. * **Treatment:** There is no cure, but symptoms can be managed with medication, lifestyle changes, and alternative therapies. * **Prognosis:** Variable, with some people experiencing a gradual improvement in symptoms over time, while others experience a worsening of symptoms. ## Significance ME/CFS is a significant public health concern, with a profound impact on the quality of life of those affected. The illness is often misunderstood, and people with ME/CFS may experience stigma, isolation, and lack of support. Research is ongoing to better understand the underlying mechanisms of ME/CFS and to develop effective treatments. In the meantime, it is essential to raise awareness about the illness and to provide support to those affected. INFOBOX: - Name: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - Type: Chronic and debilitating illness - Date: Recognized as a legitimate medical condition by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) in the 1990s - Location: Affects people worldwide - Known For: Profound fatigue, sleep disturbances, memory and concentration problems, pain, and post-exertional malaise (PEM) TAGS: Chronic fatigue syndrome, myalgic encephalomyelitis, post-exertional malaise, fatigue, sleep disturbances, memory and concentration problems, pain, viral infections, immune system dysfunction, genetic predisposition, diagnosis, treatment, prognosis, public health concern, stigma, isolation, lack of support, research, awareness, support.
Health & MedicineOCD
** Obsessive–compulsive disorder (OCD) is a chronic mental health condition marked by unwanted, intrusive thoughts (obsessions) and repetitive actions (compulsions) performed to alleviate the anxiety those thoughts generate, often causing significant functional impairment. **CONTENT:** ## Overview Obsessive–compulsive disorder (OCD) is classified as an **anxiety‑related neuropsychiatric disorder**. Individuals experience **obsessions**—persistent, unwanted mental images, urges, or thoughts that feel intrusive and distressing. To neutralize the anxiety produced by these obsessions, they engage in **compulsions**, which are ritualized behaviors or mental acts (e.g., washing, checking, counting, praying) that must be performed according to strict rules or until a feeling of “just right” is achieved. While the compulsions may temporarily reduce distress, they reinforce the obsessive–compulsive cycle, leading to escalating time consumption and functional decline in work, school, relationships, and self‑care. The prevalence of OCD is roughly **2 % of the global population**, affecting men and women equally, though onset typically occurs in late childhood or early adulthood. The disorder is highly heterogeneous; some patients are dominated by contamination fears and cleaning rituals, while others are preoccupied with symmetry, forbidden thoughts, or hoarding. The **Diagnostic and Statistical Manual of Mental Disorders (DSM‑5)** requires that obsessions or compulsions be time‑consuming (≥ 1 hour per day) or cause clinically significant distress or impairment. Because the content of obsessions can be bizarre or taboo (e.g., aggressive or sexual impulses), individuals often hide their symptoms, delaying diagnosis. **When to seek professional care:** If intrusive thoughts or repetitive behaviors consume a substantial portion of the day, cause marked anxiety, or interfere with daily responsibilities, it is essential to consult a mental‑health professional promptly. Early intervention improves outcomes and reduces the risk of secondary problems such as depression, substance misuse, or severe functional decline. ## History/Background References to compulsive‑like behaviors appear in ancient texts, including **Hippocratic writings** and **biblical passages** that describe ritual washing or repetitive prayer as attempts to ward off evil. In the Middle Ages, such symptoms were frequently interpreted as **demonic possession** or moral failing, leading to punitive or exorcistic treatments. The modern clinical concept emerged in the 19th century: French psychiatrist **Jean‑Étienne Dominique Esquirol** coined “*obsessions*” in 1838, and German neurologist **Paul Ehrlich** later distinguished “*compulsions*” as separate phenomena. The term **“obsessive‑compulsive neurosis”** entered psychiatric nomenclature with **Sigmund Freud’s** psychoanalytic writings (early 1900s), though he emphasized unconscious conflict rather than biological underpinnings. A pivotal shift occurred in the 1960s–1970s when **behavioral psychologists** (e.g., B.F. Skinner, Joseph C. Mowrer) demonstrated that compulsions could be **learned responses** reinforced by anxiety reduction. The 1980 DSM‑III formally recognized OCD as a distinct disorder, and subsequent neuroimaging studies (1990s onward) identified abnormal activity in the **cortico‑striato‑thalamo‑cortical (CSTC) circuit**, supporting a neurobiological model. ## Key Information - **Epidemiology:** Lifetime prevalence ≈ 2 %; median age of onset 19 years (children: 8–12 years). - **Core symptoms:** - *Obsessions*: intrusive, unwanted, often distressing thoughts (e.g., contamination, harm, symmetry). - *Compulsions*: repetitive behaviors or mental acts performed to neutralize obsessions (e.g., washing, checking, ordering, mental counting). - **Diagnostic criteria (DSM‑5):** Presence of obsessions, compulsions, or both; time‑consuming or causing clinically significant distress/impairment; not attributable to substances or another medical condition. - **Comorbidity:** High rates of **major depressive disorder**, **generalized anxiety disorder**, **tic disorders**, and **body‑dysmorphic disorder**. - **Neurobiology:** Dysregulated CSTC loops, altered serotonin and glutamate neurotransmission, and structural differences in the **orbitofrontal cortex**, **anterior cingulate**, and **basal ganglia**. - **Treatment:** First‑line **cognitive‑behavioral therapy (CBT)** with **exposure and response prevention (ERP)**; pharmacotherapy with **selective serotonin reuptake inhibitors (SSRIs)** or clomipramine; augmentation strategies (e.g., antipsychotics) for refractory cases; emerging neuromodulation (deep brain stimulation, transcranial magnetic stimulation). - **Prognosis:** Approximately 40–60 % achieve meaningful symptom reduction with evidence‑based therapy; however, many experience chronic or relapsing courses without sustained treatment. ## Significance OCD’s impact extends beyond individual suffering; it imposes substantial **societal costs** through lost productivity, healthcare utilization, and caregiver burden. Understanding OCD has propelled advances in **neurocircuitry research**, informing treatment for other compulsive disorders such as **addiction** and **Tourette syndrome**. Public awareness campaigns have reduced stigma, yet misconceptions persist—particularly the belief that OCD is merely “being tidy” or “overly organized.” Accurate education encourages early help‑seeking and supports policy initiatives for insurance coverage of **behavioral therapies**, which remain under‑utilized despite robust efficacy. Historically, the evolution of OCD from a moral or supernatural problem to a **brain‑based disorder** exemplifies the broader shift in psychiatry toward evidence‑based, biopsychosocial models. Notable figures—ranging from **Samuel Johnson** (18th century writer) to contemporary artists and politicians—have disclosed OCD symptoms, highlighting its cross‑cultural relevance and the importance of compassionate, science‑driven care. **INFOBOX:** - **Name:** Obsessive–Compulsive Disorder - **Type:** Mental health disorder (neuropsychiatric condition) - **Date:** First clinical description 19th century (formal DSM inclusion 1980) - **Location:** Worldwide (affects all cultures and socioeconomic groups) - **Known For:** Intrusive obsessions paired with ritualized compulsions that impair daily functioning **TAGS:** OCD, mental health, anxiety disorders, psychiatry, neurobiology, psychotherapy, pharmacology, stigma